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INTRODUCTION

METHODS

RESULTS

• Thyroid cancer is the most common endocrine neoplasm
worldwide, representing 1.7% of new cancer diagnoses and
0.5% of cancer deaths each year (Baldini et al.)

• All recent cases of thyroid bed and lymph node FNAC with
simultaneous TgW testing in the Cytology Department of TJUH
were retrospectively reviewed (N= 104)
• The cytological diagnosis was confirmed and compared with the
TgW test results; cases with surgical follow-up and histological
diagnosis were identified and also reviewed
• The selected cases were divided in two groups depending on
cytological diagnosis: positive/suspicious group and negative/
non-diagnostic group

Table 2: Diagnostic outcomes on follow-up for samples with
discordant TgW/FNAC results

• The majority of thyroid cancers are primary (originating within
the gland itself), are well-differentiated, and are derived from
follicular epithelial cells
• Papillary thyroid cancer is the most common subtype
– 70-80% of all thyroid cancers
– Peak incidence in women of child-bearing age
– Generally indolent behavior, excellent prognosis with total
thyroidectomy

Figure 1: FNAC sample from
papillary thyroid cancer spread
to cervical lymph node.

– 30-90% of patients exhibit recurrent or persistent
metastasis to the cervical lymph nodes (Torres et al.) and
20% of cases present with occult cancer that is only
identifiable in the nodes without evidence of a primary
tumor (Cunha et al.)
– It is important to detect local lymph node involvement in
order to determine appropriate surgical management,
clinical follow-up, and prognosis (Baldini et al.)
• Evaluation for lymph node involvement
– Gold standard: fine needle aspiration + cytology (FNAC)
– Diagnostic pitfalls:

Table 2: All 4 of the cases reviewed with negative/non-diagnostic
FNAC and elevated TgW were positive for thyroid carcinoma on
surgical or clinical follow-up.

CONCLUSIONS
• Diagnosing lymph node involvement in well-differentiated thyroid
cancer by FNAC alone can be challenging and yield nondiagnostic specimens
• Measurement of thyroglobulin levels is important for the diagnosis
and management of metastatic or recurrent thyroid carcinoma in
patients with negative/non-diagnostic FNAC
• Patients with positive or suspicious findings on FNAC generally
undergo neck dissection regardless of TgW test results
• Our data supports the recommendation that reflex TgW testing be
reserved for cases with negative or non-diagnostic cytology as a
cost-effective and time-saving measure

RESULTS
Table 1: Results of thyroglobulin wash testing

• Cystic change – very common in head and neck cancers, especially
papillary thyroid cancer (Ustun et al.)
• Micrometastases

– Thyroglobulin wash testing (TgW)
• Syringe used for FNAC flushed with normal saline
• Tg level in washout fluid measured using chemiluminescent assay
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